Boardwalk Antibacterial Handsoap Refill Recalled for Microbial Specification Failure
Midlab Incorporated is recalling boardwalk Antibacterial Handsoap Refill due to out-of-specification microbial test results. Affected lot 0711241 was distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses or injuries. The hazard is out-of-specification microbial contamination in a hygiene product, representing low-risk contamination in a precautionary manufacturing-defect recall context.
Plain-English summary
Midlab Incorporated is recalling boardwalk Antibacterial Handsoap Refill (Chloroxylenol 0.1%, 1-gallon/3.78-liter bottles) manufactured for Essendant Co. due to current Good Manufacturing Practice (cGMP) deviations. Microbial testing results for this product were found to be out of specification.
The affected product is lot 0711241, which was distributed nationwide in the USA.
Consumers who possess this handsoap should discontinue use and discontinue dispensing it. Those who have used the recalled product and have health concerns may contact their healthcare provider.
The recalled product
- Product
- boardwalk ANTIBACTERIAL HANDSOAP REFILL, Chloroxylenol 0.1%, 1 gal. (3.78 L), Manufactured for Essendant Co., One Parkway North, Deerfield, IL 60015
- Manufacturer
- Midlab Incorporated
- Category
- Drug — Antimicrobial Handsoap
- Hazard
- microbial-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot 0711241
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27